| At a glance | 2000 | 2011 | 2021 | 2030 | 2045 |
|---|---|---|---|---|---|
| Diabetes estimates (20-79 y) | |||||
| People with diabetes, in 1,000s | - | 1,435.1 | 2,013.0 | 2,527.5 | 3,497.9 |
| Age-adjusted comparative prevalence of diabetes, % | - | 7.0 | 7.1 | 7.6 | 8.1 |
| People with undiagnosed diabetes, in 1,000s | - | 883.6 | 810.1 | - | - |
| Proportion of people with undiagnosed diabetes, % | - | - | 40.2 | - | - |
| Impaired glucose tolerance (IGT) estimates (20-79 y) | |||||
| People with IGT, in 1,000s | - | 1,186.8 | 1,590.6 | 1,964.9 | 2,558.0 |
| Age-adjusted comparative prevalence of IGT, % | - | 5.7 | 5.2 | 5.5 | 5.6 |
| Impaired fasting glucose (IFG) estimates (20-79 y) | |||||
| People with IFG, in 1,000s | - | - | 2,966.9 | 3,610.5 | 4,775.0 |
| Age-adjusted comparative prevalence of IFG, % | - | - | 9.8 | 10.1 | 10.4 |
| Mortality attributable to diabetes (20-79 y) | |||||
| Deaths attributable to diabetes | - | 9,395.0 | 21,749.0 | - | - |
| Proportion of diabetes-related deaths in people under 60 y, % | - | - | 3.4 | - | - |
| Type 1 diabetes estimates in children and adolescents | |||||
| New cases of type 1 diabetes (0-14 y), in 1,000s | - | 0.1 | 4.9 | - | - |
| New cases of type 1 diabetes (0-19 y), in 1,000s | - | - | 6.5 | - | - |
| Type 1 diabetes (0-14 y), in 1,000s | - | - | 31.0 | - | - |
| Type 1 diabetes (0-19 y), in 1,000s | - | - | 50.8 | - | - |
| Hyperglycaemia in pregnancy (HIP) (20-49 y) | |||||
| Live births affected by HIP | - | - | - | - | - |
| Prevalence of gestational diabetes mellitus (GDM), % | - | - | - | - | - |
| Live births affected by other types of diabetes first detected in pregnancy | - | - | - | - | - |
| Live births affected by other types of diabetes detected prior to pregnancy | - | - | - | - | - |
| Diabetes-related health expenditure | |||||
| Total diabetes-related health expenditure, USD million | - | - | 1,736.8 | 2,092.9 | 2,533.0 |
| Total diabetes-related health expenditure, ID million | - | - | 6,534.8 | 7,874.5 | 9,530.6 |
| Diabetes-related health expenditure per person, USD | - | 415.0 | 862.8 | 1,039.7 | 1,258.3 |
| Diabetes-related health expenditure per person, ID | - | - | 3,246.3 | 3,911.8 | 4,734.5 |
| Demographics | |||||
| Total adult population (20-79 y), in 1,000s | - | 22,619.9 | 27,196.2 | 31,204.9 | 39,895.8 |
| Population of children (0-14 y), in 1,000s | - | - | 13,793.3 | - | - |
| Population of children and adolescents (0-19 y), in 1,000s | - | - | 16,817.6 | - | - |
| Complications of diabetes | |||||
| Microvascular |
| ||||
| Macrovascular |
| ||||